Introduction
Infectious agents are now being implicated more frequently as causes of diseases that have been considered previously to be of non-infectious aetiology. Spurred on by the most well-known examples (e.g., Helicobacter pylori and peptic ulceration), modern research is uncovering more such associations, ranging from the tenuous to the tenacious. Coronary heart disease (CHD) is a case in point. The benefits derived from elucidating infectious factors in this disease state could be enormous if prevention of transmission or microbial cure were achieved. To date, a large amount of factual data points a suspicious finger at several pathogens in the aetiology of CHD; but how convincing is the evidence and, if infectious agents are shown to have a role in CHD, how important is that role and, more importantly, can CHD thereby be rendered preventable or curable?
Atherosclerosis
Atherosclerosis is the main pathological process involved in CHD and is, logically, the first place to look for infectious aetiology. The process of atherosclerosis itself provides the first hints of potential infectious cause, with its characteristic inflammatory cell infiltrate in the lipid streaks seen in some children and young adults. 'Foamy' macrophages feature prominently in these early lesions, which seem to be progenitor lesions of the atherosclerotic process. Smooth muscle proliferation, with subsequent intimal thickening, luminal narrowing and endothelial degeneration constitute the natural history of atherosclerosis, with the severity and speed of these changes being influenced by factors that include smoking, hypertension, diabetes, dyslipidaemias and age. Not all atherosclerotic lesions progress through this full spectrum of disease but, in severe cases, the changes outlined above may lead to thrombosis, embolus or degrees of ischaemia that result in the clinical manifestations of acute or chronic coronary heart disease. Of course, arteries other than the coronary vessels can be affected, giving rise to different clinical syndromes, but for simplicity this review will deal only with the coronary vasculature.
Early predisposing events
What factor (or factors) begins this series of events in early childhood when the first histological changes become apparent? The inflammatory nature of the early cellular infiltrate suggests that either infection or autoimmune phenomena, or a combination thereof, are avenues to explore, with viruses, bacteria and nonviral obligatory intracellular parasites all being implicated as potential precipitants of the atherosclerotic process. At the other end of the disease's progression is the possibility of infection acutely triggering myocardial infarction (MI). Recent febrile illness has been associated significantly with MI [ 11, and viral infection can produce an acute coronary arteritis [2] . Add to this the coronary vasculitic and aneurysmal changes pathognomonic of Kawasaki disease (which may ultimately prove to be infectious in origin [3]), and infection may be seen as having at least two possible main pathogenetic portals into the natural history of CHD.
Viruses

Cardiotropic viruses
Cardiotropic viruses were first implicated in the pathogenesis of CHD in 1968 when experimental Coxsackie B4 virus infection in mice was shown to produce acute coronary arteritis [4] . Encouraged by this finding, and the report of MI occurring in two normolipidaemic male patients following a recent unknown viral illness [2] , other investigators sought a link between Coxsackie B virus and CHD [5-81. The lack of control groups in those studies supporting a link [5, 61, and the absence of an association in those studies which were controlled adequately [7, 81, led to a falling-off of interest in this particular virus and acute MI. Nevertheless, the stage was set for further investigations.
Herpesviridae
It is perhaps surprising that members of the family Herpesviridae, not classically considered as cardiotropic, should emerge as candidates for the initiation (and perhaps the evolution) of atherosclerosis. Some viruses cause tissue lesions which are monoclonal in nature. This may be caused, in part, by transforming abilities that can be seen in cell lines infected by viruses such as Rous sarcoma virus and the Papova virus grouping. What is unusual is the finding that the smooth muscle cells in atherosclerotic plaques are monoclonal in nature [S] , thus implying that atherosclerotic plaques may be considered as vascular tumours. This has several implications for theories exploring the initiation of atherosclerosis, not least of which is that of a viral causation. Obvious candidates would be those viruses whose ubiquity equals that of atherosclerosis and those that exhibit transforming abilities. The herpesviruses are a highly prevalent family of viruses, and some of their members affecting man have been shown to possess transforming abilities (e.g., herpes simplex virus (HSV) 11, cytomegalovirus (CMV) and EpsteinBarr virus). Other members of the family have been implicated strongly in the aetiology of tumours (e.g., human herpesvirus VIII and Kaposi's sarcoma virus). Marek's disease virus, a herpesvirus causing disease in chickens, has been shown to cause coronary artery atherosclerosis in these animals [lo] . This has focused research on the more familiar members of the herpesvirus family. HSV genomic material has been demonstrated by in-situ hybridisation in smooth muscle cells of normal and abnormal aortic tissue obtained at coronary bypass surgery from patients with atherosclerosis [ll] . Of further interest is the fact that the genomic material detected was mRNA, suggesting that the viruses detected were not merely latent cellular passengers but were actively replicating pathogens. Similar findings occurred in a study of arterial tissues of young trauma victims [ 121.
Further evidence solidifying the role of HSV in atherosclerosis is lacking, but CMY another herpesvirus, has been implicated more strongly as a potential atherogenic agent. The earliest evidence comes from in-situ hybridisation techniques that demonstrated CMV-specific nucleic acid sequences in cells derived from advanced atherosclerotic plaques [ 131. This evidence was followed by electron microscopic demonstration of herpesviruses in atheromatous tissue [ 141. The association was strengthened further by the demonstration with in-situ dot-blot hybridisation, and the detection by polymerase chain reaction (PCR), of whole CMV genomes in coronary arteries of patients with severe atherosclerosis (90% of samples as compared with 50% of samples from patients with mild or no atherosclerosis in one study [15] ). More recently, CMV nucleic acid sequences have been detected in early lesions of atherosclerosis in young trauma victims without symptomatic disease [ 121 (found in tandem with HSV in this study), and CMV-specific proteins have been detected in smooth muscle cells cultured from segments of coronary artery which have restenosed following angioplasty [ 161. CMV seropositivity has also been classified as a risk factor for pre-transplant coronary atherosclerosis in the younger age groups of a cardiac transplant population studied in the USA [17] . However, crucially, efforts to find evidence of active CMV replication within atheromatous tissue (CMV-specific mRNA detection by PCR) have so far met with little success [18] . Lastly, CMV may also be a significant factor in post-transplant arteriopathic changes. Cardiac allograft vasculopathy (CAV) is a post-cardiac transplant phenomenon which, by affecting the coronary arteries of the transplant, can cause substantial posttransplant morbidity and mortality. CAV resembles 'conventional' coronary atherosclerosis at many points of its histopathological spectrum, apart from its rapidity of development [19] , and active CMV infection occurring post-transplant has been associated with CAV in the clinical setting [20-221.
So the evidence of a role for herpesviruses in CHD has accumulated in the patient setting, but the ubiquity of these viruses makes interpretation of clinically based studies difficult. However, molecular evidence is available. The expression of receptors seen in vitro on HSV-infected cells, which are capable of binding monocytes [23] , in theory may be significant in the early stages of atherosclerosis when 'foamy' macrophages (essentially lipid-accumulating monocytes) appear in the media of the vessel wall. In the laboratory, HSV can infect fetal smooth muscle cells [ 111 and has been seen to promote accumulation of cholesteryl esters and lipids in the same cells in culture [.24 ]. In addition, HSV may cause some of the pathology that occurs relatively late in the atherosclerotic process. Atherosclerotic plaques may become thrombosed, leading to MI and other phenomena such as cerebrovascular accidents. HSV may enhance thrombus formation by virtue of the propensity of infected cells to bind platelets in vitro and generate thrombin [25] . Finally, if the monoclonal smooth muscle proliferation seen in atherosclerosis is considered as a benign tumour, then the presence of a transforming principle [26] in extracts obtained from atherosclerotic plaques assumes great significance for a viral aetiology.
Bacteria
Bacteria have also featured prominently in the search for infectious causes of CHD and two recently discovered pathogens are at the centre of ongoing research efforts.
Chlamydia pneumoniae
C. pneumoniae, a member of the family Chlamydiaceae, causes lower and upper respiratory tract infection, conjunctivitis, and has been implicated in the aetiology of endocarditis, sarcoidosis and asthma [27] . Controlled sero-epidemiological studies conducted in Finland in the late 1980s showed an association between the presence of IgG and IgA to C. pneumoniae and a diagnosis of angina pectoris [28] . Furthermore, the association between the presence of anti-chlamydia1 IgM and acute myocardial infarct (AMI) suggested that recent primary infection or reactivated infection might predispose to AM1 [28] . Further evidence has since accumulated from sero-epidemiological studies in Finland [29] and other countries , and direct evidence of the presence of C. pneumoniae in atherosclerotic lesions from healthy young South African adults has also been acquired via PCR, immunocytochemical staining and electron microscopy [ 331. In the later sero-epidemiological studies, confounding risk factors (e.g., smoking) were discounted by statistical methods. However, epidemiological discrepancies still exist. Perhaps the most major of these is the high seroprevalence of antibodies to C. pneumoniae in peri-equatorial countries where CHD is not a major public health problem [34] . Clearly, this discrepancy needs to be resolved as part of ongoing research efforts.
Helicobacter pylori
H. pylori may yet be able to add another 'noninfectious' disease to its trophy cabinet. Features common to the epidemiology of peptic ulceration and CHD have prompted several sero-epidemiological studies that confirmed the presence of an association which seems, statistically speaking, unrelated to other risk factors common to the two disease states [32, 351. Recent work has demonstrated for the first time the presence of H. pylori and C. pneumoniae genomic material in the coronary arteries of myocardial infarct cases at autopsy [36] .
Association with CHD
The explanation of the associations between CHD and these bacterial infections remains hidden. The presence of confounding common risk factors seems to have been neutralised by statistical methods for both C. pneumoniae and H. pylori. What remains now is to elucidate whether the associations are causal or not. A causative concept is not as fanciful as it seems initially. Bacterial infection may lead to molecular sequelae that might have effects on the initiation and maintenance of the atherosclerotic process. Of particular interest are the changes in lipid metabolism observed during gramnegative sepsis. Both serum triglyceride and very lowdensity lipoprotein (VLDL) levels increase during the acute phase of gram-negative sepsis in man, with levels of low-density lipoprotein (LDL)-cholesterol and highdensity lipoprotein (HDL) decreasing concomitantly [37] . During infection there is also a tendency for the plasma to move towards a hypercoagulable state, with plasma clotting factors increasing in concentration, increased procoagulant activity at the level of the vascular endothelium, and a shifting of prostaglandin metabolism towards thrombosis [38-401. Increased adhesion of circulating leucocytes to the vascular endothelium also occurs and, in the case of gramnegative infection, the endothelium is damaged directly by lipopolysaccharide [ 3 81. Lipopolysaccharide also affects circulating and tissue macrophages, increasing their production of free radicals. Free radicals are known to oxidise LDL, the product of which (oxidised LDL), has been shown to transform macrophages into foam cells, which are known to be important in the pathogenesis of atherosclerosis [3 81.
Whether these events occur in C. pneumoniae and H. pylori chronic infection remains to be seen. Furthermore, is there a role for these potentially predisposing events in atherogenesis and acute ischaemic episodes? Some of the acute-phase proteins may offer at least a partial answer. When present in raised concentrations in human plasma, fibrinogen has been shown to be a risk factor for CHD, and individuals seropositive for C. pneumoniae and H. pylori have been shown to possess chronically elevated levels of fibrinogen [41, 421. More recently, C-reactive protein (CRP), another acute-phase protein, has been shown to correlate with poor prognosis in unstable angina [43] and with prevalence of indirect evidence of CHD [44] when present at levels approaching the upper limit of normal. Whether high levels of acute-phase proteins mean inflammation is involved in the pathogenesis of CHD, or simply that chronically stressed myocardium produces a mild to be resolved.
Conclusions
In summary, the acute inflammatory response remains evidence for infectious causation of CHD is, at present, only circumstantial and extremely weak in some cases. The high prevalence of most of the pathogens mentioned may make it impossible to prove a causal link in retrospective studies, and prospective studies must reach adequate sizes to accommodate the many epidemiological variables that are common to potential pathogens and the process of CHD. Nevertheless, the accumulated data suggest that the issue should be resolved by further research efforts. Already, appropriate funding is being provided by certain research bodies that recognise this need. Ultimately, it could be that CHD and other atherosclerosis-based disease can be sent the way of peptic ulceration with a simple course of antibiotics or even a childhood vaccination.
